Another six-gene signature (Liu) marker [32], which included CSE1L, CSTB, MTHFR, DAGLA, MMP10, and GYS2, helped classify HCC patients into high- and low-risk groups with significant differences in their survival rates. Here, CSTB is linked to hepatocellular carcinoma.